Investors
FAQ
What is AXIM Biotechnologies, Inc.'s stock symbol?
Our stock is traded on the OTCQB under the symbol AXIM.
How can I buy AXIM shares?
You can buy AXIM shares through a broker, just as you would other securities.
How can I keep up to date with latest developments at AXIM?
You can register to receive updates announced by AXIM by submitting your email address in Email Alerts on the Investor Relations section of our website.
When was AXIM Biotechnologies, Inc. incorporated?
2010
When did AXIM Biotechnologies, Inc. become a public company?
March 2014
Where is AXIM Biotechnologies, Inc. located?
6191 Cornerstone Court, E., Suite 114,
San Diego, CA 92121
When is AXIM Biotechnologies, Inc.'s fiscal year end?
December 31st
Who is AXIM Biotechnologies, Inc.'s transfer agent?
Action Stock Transfer Corporation
2469 E. Fort Union Blvd
Suite 214
Salt Lake City, UT 84121
T: 801-274-1088
info@actionstocktransfer.com
www.actionstocktransfer.com
Who is AXIM Biotechnologies, Inc.'s independent auditor?
RBSM LLP
805 Third Avenue
Suite 902
New York, NY 10022
T: 212-868-3669
www.rbsmllp.com
Who is AXIM Biotechnologies, Inc.'s outside legal counsel?
Phillip E. Koehnke, APC
PO Box 235472
Encinitas, CA 92024
T: 858-229-8116
pek@peklaw.com
Email Alerts
Stay informed and receive company updates straight to your inbox
Recent News
AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide
Leading Diagnostic Healthcare Company Also Announces Over 50 Initial Clinic Commitments for Its Full Diagnostic Assay Platform SAN DIEGO, TBD DATE, 2022 (GLOBE NEWSWIRE) -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an...
AXIM® Biotechnologies Appoints Kurt Phinney as Chief Operating Officer to Drive Scaling and Optimization of Manufacturing Unit
Leading Diagnostic Healthcare Company Selects Accomplished Operations Executive to Spearhead Growth of Diagnostic Assays Manufacturing SAN DIEGO, CA, May 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM”...
AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays
Leading Diagnostic Healthcare Company Begins Manufacturing of Ocular Immunoglobulin (IgE), Lactoferrin Tests to Fulfill Orders From Commercialization Partner SAN DIEGO, CA, April 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- AXIM Biotechnologies, Inc. (OTCQB: AXIM)...
